Transcutaneous Electrical Nerve Stimulation Market Driven by Growing Adoption for Pain Management
The transcutaneous electrical nerve stimulation (TENS) market has seen significant growth in recent years owing to the benefits these devices offer for pain management. TENS devices work by using low-voltage electrical currents that are delivered through electrodes placed on the skin. When activated, the pulses block pain signals from reaching the brain by stimulating nerves under the skin. As a non-invasive treatment option for pain relief, TENS therapy is commonly used to treat various conditions including back pain, arthritis pain, labor pain, and post-surgical pain. Some key advantages of TENS include being drug-free, low risk of side effects, and providing on-demand pain relief. The global demand for effective and non-opioid pain management solutions has been a major factor driving the adoption of TENS devices.
The global transcutaneous electrical nerve stimulation market is estimated to be valued at US$ 5.23 Bn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031.
Key Takeaways
Geographically, North America currently dominates the Transcutaneous Electrical Nerve Stimulation Market Size owing to the region's advanced healthcare infrastructure and availability of favorable insurance coverage for pain management therapies. However, the market is witnessing rapid growth in Asia Pacific and Latin America due to increasing healthcare expenditures and massive unmet needs. Several leading equipment manufacturers are also expanding in emerging nations through strategic partnerships and collaborations.
Key players operating in the Transcutaneous Electrical Nerve Stimulation Market are Medtronic plc Abbott Laboratories, Boston Scientific Corporation, Omron Healthcare, Inc., Nevro Corp., DJO Global, Inc., Zynex Medical, COMPex, ITO Co., Ltd., Beurer GmbH, BTL, Chattanooga International, EMS Physio Ltd., BioMedical Life Systems, Inc., Current Solutions, LLC, Zewa, Inc., Walgreen Co., Pain Management Technologies, Inc., OPTP, and Roscoe Medical. These companies have established a broad portfolio of TENS devices with varying capabilities to address diverse pain needs.
The growing geriatric population worldwide has also fueled demand as age-related conditions like osteoarthritis become more prevalent. According to estimates, over 1.5 billion people suffer from non-cancer pain globally. Moreover, regulatory approvals for new advanced TENS systems and favorable reimbursement policies are encouraging more widespread adoption.
Get More Insights On Transcutaneous Electrical Nerve Stimulation Market
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian